POM-V Prescription Required Companion Animal

Metaxx 0.25 mg Chewable Tablets for Cats

Active ingredient: Meloxicam

Form

Chewable

Species

Cats

Manufacturer

Alfasan Nederland B.V.

VMD MA No.

36408/5010

What it's used for

Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures, e.g. orthopaedic and soft tissue surgery. Alleviation o...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Metaxx 0.25 mg Chewable Tablets for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of mild to moderate post-operative pain and inflammation following
surgical procedures, e.g. orthopaedic and soft tissue surgery.
Alleviation of pain and inflammation in acute and chronic musculo-skeletal
disorders.

Do not use in pregnant or lactating cats.
Do not use in cats suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cats less than 6 weeks of age or weighing less than 1.25 kg.

Issued: December 2022
AN: 01887/2021

Cats:
Very rare
(<1 animal / 10,000 animals
treated, including isolated reports):
Appetite loss, vomiting, diarrhoea,
blood in faeces*.
Lethargy*
Renal failure *.
Gastrointestinal ulceration.
Elevated liver enzymes.
* Typical adverse reactions of NSAIDs

Issued: December 2022
AN: 01887/2021
These side effects are in most cases transient and disappear following
termination of the treatment but in very rare cases may be serious or fatal. If
adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder or the national
competent authority via the national reporting system. See also section ”Contact
details” of the package leaflet.

None

i) Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive cat, as there is
a potential risk of renal toxicity.
As the chewable tablets are flavoured, store tablets out of reach of cats to
avoid accidental ingestion.
Post-operative use:
In case additional pain relief is required, multimodal pain therapy should be
considered.
Chronic musculoskeletal disorders:
Response to long-term therapy should be monitored at regular intervals by
a veterinary surgeon.
ii) Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Meloxicam and other non-steroidal anti-inflammatory drugs (NSAIDs) may
cause hypersensitivity reactions. People with known hypersensitivity to
NSAIDs should avoid contact with the veterinary medicinal product. Wash
hands after use.
Accidental ingestion by children may be harmful. Unused tablet parts
should therefore be returned into the blister and carton and stored in a safe
place. Part used tablets should be used at the time of the next dose. In
case of accidental ingestion by a child seek medical advice immediately
and show the package leaflet or the label to the physician.
iii) Other precautions
Not applicable

Other NSAIDs, diuretics, anticoagulant, aminoglycoside antibiotics and
substances with high protein binding may compete for binding and thus lead to
toxic effects. Meloxicam must not be administered in conjunction with other
NSAIDs or glucocorticosteroids. Concurrent administration of potential
nephrotoxic drugs should be avoided.
Pre-treatment with anti-inflammatory substances other than meloxicam at a single
dose of 0.2 mg/kg may result in additional or increased adverse effects and
accordingly a treatment-free period with such veterinary medicinal products
should be observed for at least 24 hours before commencement of treatment.
The treatment-free period, however, should take into account the
pharmacological properties of the products used previously.

This veterinary medicinal product does not require any special storage conditions.

The tablets can be administered with or without food.
Chewable tablets can be divided into two or four equal parts, for dosage
accuracy, according to the bodyweight.
The recommended dose should not be exceeded.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Meloxicam has a narrow therapeutic safety margin and clinical signs of overdose
may be seen at relatively small overdose levels.
In case of overdose, adverse reactions, as listed in section 4.6, are expected to
be more severe and more frequent. In case of overdose symptomatic treatment
should be initiated.
4.11 Withdrawal period(s)
Not applicable
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.